Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
Open Access
- 30 September 2016
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 7, 359
- https://doi.org/10.3389/fphar.2016.00359
Abstract
Animal studies and preliminary clinical trials have shown that cannabidiol-enriched extracts may have beneficial effects for children with treatment-resistant epilepsy. However, these compounds are not yet registered as medicines by regulatory agencies. We describe the cases of two children with treatment-resistant epilepsy (Case A with left frontal dysplasia and Case B with Dravet Syndrome) with initial symptom improvement after the introduction of CBD extracts followed by seizure worsening after a short time. The children presented typical signs of intoxication by ∆9-THC (inappropriate laughter, ataxia, reduced attention, and eye redness) after using a cannabidiol-enriched extract. The extract was replaced by the same dose of purified cannabidiol with no ∆9-THC in both cases, which led to improvement in intoxication signs and seizure remission. These cases support pre-clinical and preliminary clinical evidence suggesting that cannabidiol may be effective for some patients with epilepsy. Moreover, the cases highlight the need for randomized clinical trials using high-quality and reliable substances to ascertain the safety and efficacy of cannabinoids as medicines.Keywords
This publication has 28 references indexed in Scilit:
- Edible Cannabis Products: It Is Time for FDA OversightThe Journal of Clinical Pharmacology, 2016
- Cannabis and Neuropsychiatry, 1: Benefits and RisksThe Journal of Clinical Psychiatry, 2016
- Cannabidiol and epilepsy: Rationale and therapeutic potentialPharmacological Research, 2016
- Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent PsychosisCNS & Neurological Disorders - Drug Targets, 2015
- Cannabinoids in the Treatment of EpilepsyNew England Journal of Medicine, 2015
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis ProductsPublished by American Medical Association (AMA) ,2015
- Phytocannabinoids and epilepsyJournal of Clinical Pharmacy & Therapeutics, 2014
- Internet Highs—Seizures After Consumption of Synthetic Cannabinoids Purchased OnlineJournal of Addiction Medicine, 2012
- [Therapeutical use of the cannabinoids in psychiatry].2010
- Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic PatientsPharmacology, 1980